MXCT vs WH · rev $38.6M vs P/E 20, rev $1.43B
MaxCyte Inc (MXCT) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WH revenue for 2025-12-31 was $1.43B. Net income was $193.0M. Revenue was up 1.5% from 2024-12-31 to 2025-12-31. WH currently screens at market cap $6.51B and trailing P/E 20.1.
MXCT currently screens at market cap $124.3M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the MXCT and WH stock pages for the full models.
Not investment advice.